Table 5.

Selected reports of comprehensive experiences with resected pancreatic ductal adenocarcinoma (PDAC), 1970 present

Author	Years	n	Mortality			Survivala					Scope
			30d	90d	Surgical	Median (months)	1-year	3-year	5-year	5-year, actual
Yeo8	1970–1994	201	5.0b	NA	NA	15.5	57	26	21	15	SI – Hopkins
Mayo56	1970–2008	1822	NA	NA	NA	18	68.3	38.9	18	NA	SI – Hopkins
Trede57	1972–1989	133	2.2b	NA	NA	NA	NA	NA	24c	NA	SI – Mannheim
Schnelldorfer58	1981–2001	357	1.4b	NA	NA	17	NA	NA	18	17.4	SI – Mayo Clinic
Conlon7	1983–1989	118	3.4	NA	NA	14.3	NA	NA	10.2	10.2	SI – MSKCC
Winter5	1983–1989	123	4.9	7.3	NA	23.2f	58	NA	17f	NA	SI – MSKCC
Geer59	1983–1990	146	3.4	NA	NA	NA	NA	NA	24	19.2	SI – MSKCC
Ferrone60	1983–2001	618	1.1	NA	NA	NA	NA	NA	NA	11.8	SI – MSKCC
Sohn6	1984–1999	616	2.3b	NA	2.3	17	63	25	17	17	SI – Hopkins
Sener61	1985–1995	9044	NA	NA	NA	NA	NA	NA	23.4	NA	NCDB
Wade62	1987–1991	252	8.3	NA	NA	15d	NA	NA	9	NA	Dept. Vet. Affairs
Cleary63	1988–1996	123	NA	NA	4.8	13.6	NA	NA	14.6	14.6	SI – Toronto
Baxter64	1988–2002	2919	NA	NA	NA	17e	NA	NA	NA	NA	SEER
Winter5	1990–1999	399	1.5	3.0	NA	25.6f	68	NA	20f	NA	SI – MSKCC
Bilimoria1	1992–1998	21512	NA	NA	NA	12.6	52	19.1	12.6	12.6	NCDB
van Geenen65	1992–1998	108	NA	NA	NA	16	NA	NA	NA	NA	SI – Amsterdam
Konstantinidis66	1993–2008	517	0.8	NA	NA	19.7	NA	NA	17.3	NA	SI – Mass General
Evans67h	1998–2001	64	1.6g	NA	NA	34	NA	NA	36	NA	SI – MD Anderson
Winter5	2000–2009	625	1.3	3.9	NA	24.5f	68	NA	8f	NA	SI – MSKCC
Present Study	2001–2011	424	0.7	1.7	1.7	21.3	76	34	23	21	DI – Penn & BIDMC

^aActuarial.

^bIn-hospital.

^cExcludes in-hospital mortalities.

^dMean.

^eCalculated from diagnosis; only includes patients that survived 3 months from diagnosis.

^fOnly includes patients that survived 1-year.

^gPeri-operative death.

^hReflects only patients who completed neoadjuvant therapy and received surgical resection.

DI, dual institution; SI, single institution. NA, not applicable.